Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 3
2005 6
2006 5
2007 7
2008 11
2009 3
2010 7
2011 4
2012 7
2013 6
2014 6
2015 8
2016 8
2017 5
2018 6
2019 5
2020 8
2021 5
2022 4
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Immunogenicity of Proteins Used as Therapeutics.
Sauna ZE, Richards SM, Maillere B, Jury EC, Rosenberg AS. Sauna ZE, et al. Among authors: maillere b. Front Immunol. 2020 Oct 29;11:614856. doi: 10.3389/fimmu.2020.614856. eCollection 2020. Front Immunol. 2020. PMID: 33193460 Free PMC article. No abstract available.
Immunogenicity of long-lasting recombinant factor VIII products.
Ing M, Gupta N, Teyssandier M, Maillère B, Pallardy M, Delignat S, Lacroix-Desmazes S; ABIRISK consortium. Ing M, et al. Among authors: maillere b. Cell Immunol. 2016 Mar;301:40-8. doi: 10.1016/j.cellimm.2015.12.006. Epub 2015 Dec 19. Cell Immunol. 2016. PMID: 26723503 Free article. Review.
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.
Antunes A, Alvarez-Vallina L, Bertoglio F, Bouquin N, Cornen S, Duffieux F, Ferré P, Gillet R, Jorgensen C, Leick MB, Maillère B, Negre H, Pelegrin M, Poirier N, Reusch D, Robert B, Serre G, Vicari A, Villalba M, Volpers C, Vuddamalay G, Watier H, Wurch T, Zabeau L, Zielonka S, Zhang B, Beck A, Martineau P. Antunes A, et al. Among authors: maillere b. MAbs. 2023 Jan-Dec;15(1):2211692. doi: 10.1080/19420862.2023.2211692. MAbs. 2023. PMID: 37184206 Free PMC article.
Specificity of the T Cell Response to Protein Biopharmaceuticals.
Meunier S, de Bourayne M, Hamze M, Azam A, Correia E, Menier C, Maillère B. Meunier S, et al. Among authors: maillere b. Front Immunol. 2020 Jul 22;11:1550. doi: 10.3389/fimmu.2020.01550. eCollection 2020. Front Immunol. 2020. PMID: 32793213 Free PMC article. Review.
[The prediction of immunogenicity of therapeutic proteins].
Maillère B, Delluc S, Ravot G. Maillère B, et al. Med Sci (Paris). 2012 Jan;28(1):82-8. doi: 10.1051/medsci/2012281021. Epub 2012 Jan 27. Med Sci (Paris). 2012. PMID: 22289835 Free article. Review. French.
Monoepitopic anti-FVIII T-cell response.
Lacroix-Desmazes S, Maillere B. Lacroix-Desmazes S, et al. Among authors: maillere b. Blood. 2016 Oct 20;128(16):1999-2001. doi: 10.1182/blood-2016-08-732123. Blood. 2016. PMID: 28157675 Free article. No abstract available.
State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop.
van Vliet E, Kühnl J, Goebel C, Martinozzi-Teissier S, Alépée N, Ashikaga T, Blömeke B, Del Bufalo A, Cluzel M, Corsini E, Delrue N, Desprez B, Gellatly N, Giese C, Gribaldo L, Hoffmann S, Klaric M, Maillere B, Naisbitt D, Pallardy M, Vocanson M, Petersohn D. van Vliet E, et al. Among authors: maillere b. ALTEX. 2018;35(2):179-192. doi: 10.14573/altex.1709011. Epub 2017 Oct 2. ALTEX. 2018. PMID: 28968481 Free article.
116 results